Everist Genomics, Inc. is a personalized medicine company that developed the ANGIODEFENDER system. This device is the world’s first integrated diagnostic product that combines sensor technology with a software algorithm to help doctors swiftly and economically detect early-stage cardiovascular disease (CVD).

Industry Categories

Industry Biomedical
Sub-industry
Focus Areas
Focus Areas - detailed

University

University Rutgers
Principal Investigator Matthew Bartlam, MBA

Company

Web http://everisthealth.com
Incubator / Accelerator / Lab Facility
Address Ann Arbor, MI
Phone
Email

Timeline

  • 2001 – Founded

No files attached to this page.

Add a New Comment